Mayne To Begin Selling Generic Morphine Drugs In The US


Mayne Pharma Group has announced receiving FDA approval to begin selling generic drugs containing morphine in the US market. The drugs, extended release tablets (MSER), are a generic version of MS Contin. MS Contin is an opiod analgesic. The extended release tablets had sales of $280 million for the 12 months preceding August 31st, 2016. Mayne Pharma is looking to expand its generic offerings in the US market.

Read the source article at Finance News Network

About the Author

Related Posts

Leave a Reply